Crossmark

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials

Crossref DOI link: https://doi.org/10.1186/s12885-022-09444-0

Published Online: 2022-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Pengfei

Zhen, Hongchao

Zhao, Hong

Zhao, Lei

Cao, Bangwei
License Information

Text and Data Mining valid from 2022-03-26

Version of Record valid from 2022-03-26
More Information

Article History

Received: 24 December 2021

Accepted: 23 March 2022

First Online: 26 March 2022

Declarations

:

: Not applicable.

: Not applicable.

: All the authors declared that they had no competing interest.

Document is current

Any future updates will be listed below